newsfilter
← Latest News
GlobeNewswire·

Metsera Reports Second Quarter 2025 Financial Results and Continued Portfolio Progress

MET-097i (fully biased once-monthly GLP-1 RA) VESPER-1 and interim VESPER-3 data release expected in September 2025; Phase 3 initiation on track for late 2025 MET-233i (once-monthly amylin analog) delivered